Julie Liu

Julie Liu has worked at several companies in various roles. Julie began their career at Pfizer in 2000 as a Research Scientist, where they designed and developed advanced cell-based assays and in vitro enzymatic assays. In 2012, they joined X-Chem, Inc. as a Principal Scientist, where they increased their responsibility over the years and led the X-Chem Protein biochemistry group. In 2020, they joined Civetta Therapeutics as a Principal Scientist, where they worked in cross-functional teams as a Biochemical and Biophysics lead. Most recently, in 2021, they joined Accent Therapeutics, Inc. as an Associate Director and Principal Scientist.

Julie Liu has a Master's degree in Biochemistry from Shanghai Medical University.